(UTMD) Utah Medical Products - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9174881089
UTMD: Medical Devices, Fetal Monitoring, Catheters, Electrodes, Surgical Tools
Utah Medical Products, Inc. (NASDAQ:UTMD) is a global developer, manufacturer, and distributor of medical devices tailored for the healthcare industry. The company specializes in products for neonatal intensive care, labor and delivery, and womens health. Its portfolio includes fetal monitoring accessories, vacuum-assisted delivery systems, and infant respiratory hoods. UTMD also manufactures umbilical vessel catheters, oral protection devices, urinary drainage systems, and feeding devices. Additionally, the company provides instruments for cervical intraepithelial neoplasia treatment, electrosurgical devices, and tools for laparoscopic procedures. Its customer base spans hospitals, outpatient clinics, and physician offices worldwide.
Over the next three months, based on
Additional Sources for UTMD Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
UTMD Stock Overview
Market Cap in USD | 191m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Health Care Supplies |
IPO / Inception | 1999-03-08 |
UTMD Stock Ratings
Growth 5y | -39.5% |
Fundamental | 42.1% |
Dividend | 42.5% |
Rel. Strength Industry | -16.9 |
Analysts | - |
Fair Price Momentum | 51.52 USD |
Fair Price DCF | 118.72 USD |
UTMD Dividends
Dividend Yield 12m | 1.97% |
Yield on Cost 5y | 1.65% |
Annual Growth 5y | 1.38% |
Payout Consistency | 63.4% |
UTMD Growth Ratios
Growth Correlation 3m | -77.3% |
Growth Correlation 12m | -83.3% |
Growth Correlation 5y | -31.2% |
CAGR 5y | -4.85% |
CAGR/Max DD 5y | -0.09 |
Sharpe Ratio 12m | -1.99 |
Alpha | -23.92 |
Beta | 0.55 |
Volatility | 15.14% |
Current Volume | 13.7k |
Average Volume 20d | 18.6k |
As of March 16, 2025, the stock is trading at USD 57.30 with a total of 13,664 shares traded.
Over the past week, the price has changed by -1.89%, over one month by -5.64%, over three months by -8.49% and over the past year by -16.12%.
Partly, yes. Based on ValueRay Fundamental Analyses, Utah Medical Products (NASDAQ:UTMD) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.10 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UTMD as of March 2025 is 51.52. This means that UTMD is currently overvalued and has a potential downside of -10.09%.
Utah Medical Products has no consensus analysts rating.
According to ValueRays Forecast Model, UTMD Utah Medical Products will be worth about 56.5 in March 2026. The stock is currently trading at 57.30. This means that the stock has a potential downside of -1.43%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 56.5 | -1.4% |